Literature DB >> 12568912

Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor.

Ester Fride1, Anat Foox, Elana Rosenberg, Moran Faigenboim, Vickey Cohen, Lena Barda, Hannah Blau, Raphael Mechoulam.   

Abstract

Cannabinoids, whether plant-derived, synthetic or endogenous, have been shown to stimulate appetite in the adult organism. We have reported previously that cannabinoid receptors play a critical role during the early suckling period: The selective cannabinoid CB(1) receptor antagonist N-(piperidiny-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141617A) permanently prevented milk ingestion in a dose-dependent manner, when administered to (Sabra, albino) mouse pups, within 1 day of birth. As a consequence, these pups died within the first week of life. We now generalize this finding to a different strain of mice (C57BL/6). Further, we show that cannabinoid CB(1) receptor blockade (20 mg/kg SR141716A) must occur within 24 h after birth as injection of SR141716A into 2- or 5-day-old pups had a much smaller effect or no effect at all, respectively. Cannabinoid CB(1) receptor knockout mice did not ingest milk on the first day of life, similarly to SR141716A-treated normal pups, as measured by the appearance of "milkbands". However, the knockout pups started to display milkbands from day 2 of life. Survival rates of cannabinoid CB(1) receptor knockout mice were affected significantly, but to a lesser extent than normal pups, by the administration of SR141716A. Daily administration of the endocannabinoid 2-arachidonoyl glycerol, or the synthetic agonists (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone (WIN55,212-2, 5 mg/kg) or (-)-cis-3-[2-Hydroxy4-(1,1-dimethylheptyl) phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol (CP55,940, 5 or 20 mg/kg) did not promote survival or weight gain in CB(1)(-/-) pups. Our data support previous evidence for a critical role of cannabinoid CB(1) receptors for the initiation of suckling. Further, the present observations support the existence of an unknown cannabinoid receptor, with partial control over milk ingestion in newborns. Our data also suggest that the CB(1)(-/-) neonates possess a compensatory mechanism which helps them overcome the lack of cannabinoid CB(1) receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12568912     DOI: 10.1016/s0014-2999(03)01295-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  33 in total

1.  Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.

Authors:  Catherine Lombard; Venkatesh L Hegde; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2011-08-10       Impact factor: 4.030

2.  Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism.

Authors:  Nichola J Underdown; C Robin Hiley; William R Ford
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 3.  The endocannabinoid system in brain reward processes.

Authors:  M Solinas; S R Goldberg; D Piomelli
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

4.  CB1 cannabinoid receptor-mediated modulation of food intake in mice.

Authors:  Jenny L Wiley; James J Burston; Darnica C Leggett; Olga O Alekseeva; Raj K Razdan; Anu Mahadevan; Billy R Martin
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

5.  The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase.

Authors:  Sachin Patel; Eric R Wohlfeil; David J Rademacher; Erica J Carrier; LaToya J Perry; Abhijit Kundu; J R Falck; Kasem Nithipatikom; William B Campbell; Cecilia J Hillard
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

6.  Cannabis and breastfeeding.

Authors:  Aurélia Garry; Virginie Rigourd; Ammar Amirouche; Valérie Fauroux; Sylvie Aubry; Raphaël Serreau
Journal:  J Toxicol       Date:  2009-04-29

Review 7.  Cannabinoids in multiple sclerosis: do they have a therapeutic role?

Authors:  Joep Killestein; Bernard M J Uitdehaag; Chris H Polman
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Rimonabant: the role of endocannabinoid type 1 receptor antagonism in modulating the weight and lipid profile of obese patients.

Authors:  Christopher T Dibble; Eli V Gelfand; Christopher P Cannon
Journal:  Curr Atheroscler Rep       Date:  2007-11       Impact factor: 5.113

9.  PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.

Authors:  J G Horswill; U Bali; S Shaaban; J F Keily; P Jeevaratnam; A J Babbs; C Reynet; P Wong Kai In
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

10.  Spatio-temporal expression patterns of anandamide-binding receptors in rat implantation sites: evidence for a role of the endocannabinoid system during the period of placental development.

Authors:  Bruno M Fonseca; Georgina Correia-da-Silva; Anthony H Taylor; Justin C Konje; Stephen C Bell; Natércia A Teixeira
Journal:  Reprod Biol Endocrinol       Date:  2009-10-27       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.